Escherichia coli HA-5
This strain does not exhibit an improved production of the intended metabolite when compared with its closest ancestors.
Ancestors
Genotype with respect to wild type
F− dcm gal ompT hsdS(rB- mB-) | F− ompT hsdSB (rB−mB−) gal dcm λ(DE3) | Plasmid pC-Os4CL-HCBT added | Plasmid pE-trpEG added | Plasmid pA-aroGfbr-SeTAL-tyrAfbr addedBars (|) indicate differences between strains.
Plasmids
-
pA-aroGfbr-SeTAL-tyrAfbr (TALSe, aroGfbrEc, tyrAfbrEc)
pC-Os4CL-HCBT (Os4CL, HCBT)
pE-trpEG (trpEG)
Modifications
| Origin | Gene | Organism | Modification |
|---|---|---|---|
|
Overexpression
|
|||
|
Feedback insensitive
|
|||
|
Feedback insensitive
|
|||
|
Overexpression
|
|||
|
Overexpression
|
|||
|
Overexpression
|
Production
| Metabolites | Production type | Production | Biomass | Carbon source | Time | Scale | Ref. |
|---|---|---|---|---|---|---|---|
| avenanthramide D | Titer | 34.2 mg/L | Flask | [360] | |||
| 4-coumarate | Titer | 124.22 mg/L * | Flask | [360] | |||
| anthranilate | Titer | 5.73 mg/L * | Flask | [360] | |||
| L-tyrosine | Titer | 611.52 mg/L * | Flask | [360] |
* Inferred from plots using RetroPlot.
Heterologous.
Target metabolites are shown in bold, while non-bold metabolites represent intermediates or potential byproducts.